-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 DCkugROsVTU3719Pdqvph93WU1ulhWIhm05gaf7QLJsPzpBlj9DQJznjt8w7O9LS
 1aYB38/Nkn2C3kE1Ik7z8Q==

<SEC-DOCUMENT>0001104659-06-002615.txt : 20060118
<SEC-HEADER>0001104659-06-002615.hdr.sgml : 20060118
<ACCEPTANCE-DATETIME>20060118115812
ACCESSION NUMBER:		0001104659-06-002615
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20060118
DATE AS OF CHANGE:		20060118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTRUSION INC
		CENTRAL INDEX KEY:			0000736012
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				751911917
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-130866
		FILM NUMBER:		06534840

	BUSINESS ADDRESS:	
		STREET 1:		1101 ARAPAHO ROAD
		CITY:			RICHARDSON
		STATE:			TX
		ZIP:			75081
		BUSINESS PHONE:		9722346400

	MAIL ADDRESS:	
		STREET 1:		1101 ARAPAHO ROAD
		CITY:			RICHARDSON
		STATE:			TX
		ZIP:			75081

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTRUSION COM INC
		DATE OF NAME CHANGE:	20000601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ODS NETWORKS INC
		DATE OF NAME CHANGE:	19970507

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OPTICAL DATA SYSTEMS INC
		DATE OF NAME CHANGE:	19950517
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>a06-2791_1424b5.htm
<DESCRIPTION>PROSPECTUS FILED PURSUANT TO RULE 424(B)(5)
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p style="font-weight:bold;margin:0pt 0pt 9.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="Prospectus_192359"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">PROSPECTUS</font></b></p>

<p style="font-size:10.0pt;font-weight:bold;margin:0pt 0pt 9.0pt;page-break-after:avoid;text-align:right;">FILE PURSUANT TO RULE 424(b)(5)<br>REGISTRATION NO. 333-130866</p>

<p style="font-size:10.0pt;font-weight:bold;margin:0pt 0pt 10.0pt;page-break-after:avoid;text-align:center;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;">874,444 SHARES</font><br>
<br>
</b><font size="3" style="font-size:12.0pt;">Intrusion Inc. <br>
Common Stock</font></p>

<div style="line-height:9.0pt;margin:0pt 0pt 8.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This prospectus relates to up to 874,444 shares of our
common stock that the selling stockholders named on page&nbsp;<font style="background:white;">18</font> in this prospectus, or their respective
pledgees, donees, transferees or other successors in interest that receive
these shares as a gift, partnership distribution or other non sale related
transfer, may offer for resale from time to time.</font></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Of the 874,444
shares of common stock to which this prospectus relates:</font></p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>564,607
shares underlie currently outstanding convertible preferred stock; and</p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>309,837
shares underlie currently outstanding warrants.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The prices at which these stockholders may sell the
shares will be determined by the prevailing market prices for the shares or in
negotiated transactions. We will not receive any of the proceeds from the sale
of the shares, but we will receive the exercise price of the warrants if they
are exercised for cash. If all of the warrants for which we are registering the
underlying shares of our common stock are exercised for cash, as of the date of
this prospectus, we would receive an aggregate of approximately $799,379.46</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our common stock is currently quoted on The Nasdaq
Capital Market under the symbol &#147;INTZ.&#148;&#160;
On January&nbsp;13, 2006, the closing price for our common stock as
reported by The Nasdaq Capital Market was $1.78.</font></p>

<p style="margin:0pt 0pt 6.0pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">An investment in our common stock
involves substantial risk. These risks are described under the caption &#147;Risk
Factors&#148; beginning on page&nbsp;<font style="background:white;">3</font> and the
section entitled &#147;Additional Factors That May&nbsp;Affect Future Results of
Operations&#148; in the documents we file with the Securities and Exchange
Commission that are incorporated by reference in this prospectus.</font></i></b></p>

<div style="line-height:9.0pt;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>

<p style="margin:0pt 0pt 9.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Neither
the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or determined if this prospectus is
truthful or complete. Any representation to the contrary is a criminal offense.</font></b></p>

<p align="center" style="margin:0pt 0pt 6.0pt;text-align:center;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The date of this
prospectus is January&nbsp;18, 2006.</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\1719534634_D11053_753422\2791-1-ba.htm',USER='jmsproofassembler',CD='Jan 17 19:54 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">TABLE
OF CONTENTS</font></b></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#IntrusionInc__200352" title="Click to goto ">INTRUSION INC</a>.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#RiskFactors_201917" title="Click to goto ">RISK FACTORS</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#NoteRegardingForwardlookingStatem_202828" title="Click to goto ">NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#DescriptionOfSecuritiesAndRelated_202939" title="Click to goto ">DESCRIPTION OF SECURITIES AND RELATED TRANSACTIONS</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#PlanOfDistribution_204227" title="Click to goto ">PLAN OF DISTRIBUTION</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#UseOfProceeds_223434" title="Click to goto ">USE OF PROCEEDS</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#SellingStockholders_213332" title="Click to goto ">SELLING STOCKHOLDERS</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#LegalMatters_204759" title="Click to goto ">LEGAL MATTERS</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#Experts_204759" title="Click to goto ">EXPERTS</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="574" valign="top" style="padding:0pt .7pt 0pt 0pt;width:430.4pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a06-2791_1424b5.htm#WhereYouCanFindAdditionalInformat_204759" title="Click to goto ">WHERE YOU CAN FIND ADDITIONAL INFORMATION</a></font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="display:none;font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

</div>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\1723342932_D11389_753648\2791-1-bg.htm',USER='jmsproofassembler',CD='Jan 17 23:04 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="IntrusionInc__200352"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">INTRUSION INC.</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="General_200408"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">General</font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We develop, market and support a family of regulated
information compliance and data protection products, entity identification
systems along with network intrusion prevention and detection systems that
address vital security issues facing organizations with mission critical
business applications or housing classified, confidential or customer
information assets. Our products include Compliance Commander&#153; for regulated
information and data privacy protection, TraceCop&#153; for entity identification
and location, SpySnare&#153; for real-time inline blocking of spyware and unwanted
peer-to-peer applications, and SecureNet&#153; for network intrusion prevention and
detection.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We market and distribute our products through a direct
sales force to end-users and distributors and by numerous domestic and
international system integrators, managed service providers and value-added
resellers. Our end-user customers include high technology, manufacturing,
telecommunications, retail, transportation, healthcare, insurance,
entertainment, utilities and energy companies, government entities, financial
institutions and academic institutions.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We were organized in Texas in September&nbsp;1983 and
reincorporated in Delaware in October&nbsp;1995. For more than 15 years, we
provided local area networking equipment and were known as Optical Data Systems
or ODS Networks. On June&nbsp;1, 2000, we changed our name from ODS Networks,&nbsp;Inc.
to Intrusion.com,&nbsp;Inc., and our NASDAQ ticker symbol from ODSI to INTZ to
reflect our focus on intrusion detection solutions. On November&nbsp;1, 2001,
we changed our name from Intrusion.com,&nbsp;Inc. to Intrusion Inc.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our principal executive
offices are located at 1101 East Arapaho Road, Richardson, Texas 75081, and our
telephone number is (972) 234-6400. Our website URL is www.intrusion.com.
Information contained in or linked to our website are not a part of this
prospectus. References to &#147;we,&#148; &#147;us&#148; and &#147;our&#148; in this prospectus refer to Intrusion
Inc. and its subsidiaries.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="ThisProspectus_200425"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Prospectus</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This prospectus relates to
up to 874,444 shares of our common stock that the selling stockholders listed
on page&nbsp;<font style="background:white;">18</font>, or their respective
pledgees, donees, transferees or other successors in interest that receive
these shares as a gift, partnership distribution or other non-sale related
transfer, may offer for resale from time to time. These shares represent shares
of our common stock underlying shares of our convertible preferred stock and
warrants that were issued to the selling stockholders in various transactions. These
transactions are summarized below and are more fully described under the
section entitled &#147;<i><font style="font-style:italic;">Description of Securities
and Related Transactions</font></i>&#148; beginning on page&nbsp;<font style="background:white;">7</font> of this prospectus.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="TheTransactions_200557"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Transactions</font></b></p>

<p style="font-style:italic;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Private Placement</font></i></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On December&nbsp;2, 2005, we entered into a Securities
Purchase Agreement with various investors, including G. Ward Paxton, our
Chairman, President and Chief Executive Officer, and James F. Gero, a member of
our Board of Directors, pursuant to which the investors purchased 564,607
shares of our Series&nbsp;3 5% convertible preferred stock and warrants to
purchase up to 282,306 shares of our common stock. Mr.&nbsp;Paxton and Mr.&nbsp;Gero
invested an aggregate of $180,000 in the private placement in exchange for
82,569 shares of the preferred stock and warrants to purchase an aggregate of
41,285 shares of our common stock.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our agreements with these
investors require us to register all 846,913 shares of our common stock
underlying these shares of preferred stock and warrants. These shares cover the
number of shares of our common stock issuable by us upon conversion of the
preferred stock and upon the exercise of the warrants, </font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">1</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='1',FILE='C:\fc\17223633128_D11389_753616\2791-1-da.htm',USER='jmsproofassembler',CD='Jan 17 22:37 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">including
the 123,854 shares of common stock underlying the preferred stock and warrants
acquired by Mr.&nbsp;Paxton and Mr.&nbsp;Gero.</font></p>

<p style="font-style:italic;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compensation of
Placement Agent</font></i></p>

<p style="margin:0pt 0pt 18.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stonegate Securities,&nbsp;Inc.
acted as our placement agent in connection with the private placement. As part
of its compensation, we issued warrants to purchase an aggregate of the 27,531
shares of our common stock to two affiliates of Stonegate. This prospectus
includes all of these shares.</font></p>

<div style="line-height:9.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">2</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='2',FILE='C:\fc\17223633128_D11389_753616\2791-1-da.htm',USER='jmsproofassembler',CD='Jan 17 22:37 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="RiskFactors_201917"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">RISK FACTORS</font></b></p>

<p style="font-style:italic;margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">You should carefully consider the risks below and
those contained in the section entitled &#147;Factors That May&nbsp;Affect Future
Results of Operations&#148; in the documents we file with the SEC that are
incorporated by reference in this prospectus, specifically the factors included
in our Form&nbsp;10-KSB for the year ended December&nbsp;31, 2004, and our Form&nbsp;10-QSB
for the quarter ended September&nbsp;30, 2005, before making an investment
decision. The risks described below and incorporated herein are those we
currently believe may materially affect us.</font></i></p>

<p style="font-style:italic;font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="CertainRightsOfTheHoldersOfOurPre_202003"></a><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain rights of the holders of our preferred stock
may hinder our ability to raise additional financing.</font></i></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We cannot issue shares of
capital stock with rights senior to those of our existing 5% preferred stock, Series&nbsp;2
5% preferred stock or Series&nbsp;3 5% preferred stock without the approval of
at least a majority of the holders of our 5% preferred stock, all of the
holders of our Series&nbsp;2 5% preferred stock, and holders of at least 75% of
our Series&nbsp;3 5% preferred stock voting or acting as separate classes. We
also cannot incur certain indebtedness without the approval of at least a
majority of the holders of our 5% preferred stock. In addition, holders of the Series&nbsp;3
5% preferred stock who are not executive officers or directors have the right
to purchase a pro rata portion of certain future issuances of securities by us.
The combination of these provisions could hinder or delay our ability to raise
additional debt or equity financing.</font></p>

<p style="font-style:italic;font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:0pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">You will experience
substantial dilution upon the conversion or redemption of the shares of
preferred stock and the exercise of warrants that we issued in our recent
private placements.</font></i></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March&nbsp;25, 2004, we completed a $5,000,000
private placement in connection with which we issued 1,000,000 shares of our 5%
Convertible Preferred Stock and warrants to acquire 556,619 shares of our
common stock. The conversion price for the preferred stock and the exercise
price of the warrants is $3.144 per share. We also issued our placement agent a
warrant for 64,408 shares of our common stock at an exercise price of $3.144
per share. As of January&nbsp;13, 2006, there were 259,696 shares of 5%
preferred stock, representing approximately 413,003 shares of common stock upon
conversion, and warrants to purchase 556,619 shares of common stock
outstanding.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, on March&nbsp;28, 2005, we completed a
$2,663,000 private placement in connection with which we issued 1,065,200
shares of our Series&nbsp;2 5% Convertible Preferred Stock and warrants to
acquire 532,600 shares of our common stock. We also issued two affiliates of
our placement agent warrants to purchase an aggregate of 60,390 shares of
common stock. The conversion price for the preferred stock is $2.50 per share
and the exercise price of the warrants is $2.77 per share. As of January&nbsp;13,
2006, there were 500,000 shares of Series&nbsp;2 5% preferred stock,
representing 500,000 shares of common stock upon conversion, and warrants to
purchase 532,600 shares of common stock outstanding.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Finally, on December&nbsp;2, 2005, we completed a
$1,230,842.92 private placement in connection with which we issued 564,607
shares of our Series&nbsp;3 5% preferred stock and warrants to acquire 282,306
shares of our common stock. We also issued two affiliates of our placement
agent warrants to purchase an aggregate of 27,531 shares of common stock. The
conversion price of the preferred stock is $2.18 per share and the exercise
price of the warrants is $2.58 per share. As of January&nbsp;13, 2006, there
were 564,607 shares of Series&nbsp;3 5% preferred stock, representing 564,607
shares of common stock upon conversion, and warrants to purchase 282,306 shares
of common stock outstanding.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On January&nbsp;13, 2006, we had 6,909,507 shares of
common stock outstanding. As a result, we expect the private placements to result
in a further dilution to holders of our common stock upon conversion of the
preferred stock and exercise of the warrants of 3,001,464 shares of common
stock, or an approximately 43.4% increase in the number of shares of our common
stock outstanding.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">3</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='3',FILE='C:\fc\1892815317_D11188_754376\2791-1-dc.htm',USER='jmsproofassembler',CD='Jan 18 09:28 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Further, the occurrence of
certain specified events described below under &#147;<i><font style="font-style:italic;">Description of Securities and Related Transactions&#151;Terms of the Series&nbsp;3
5% Convertible Preferred Stock&#151;Redemption</font></i>&#148; entitle holders of our Series&nbsp;3
5% preferred stock to require us to redeem their shares for a number of shares
of our common stock equal to the redemption price divided by 75% of the ten-day
average of the volume weighted average price of our common stock ending on the
day immediately preceding the holder&#146;s election to redeem, subject to a floor
of $0.87 per share. Holders of our Series&nbsp;2 5% preferred stock have
similar redemption rights without a floor. The redemption price for the shares
of Series&nbsp;3 5% preferred stock equals the sum of (1)&nbsp;the greater of
$2.834 and the volume weighted average price of our common stock on the trading
day immediately preceding the redemption event multiplied by $2.18 divided by
the conversion price of the Series&nbsp;3 5% preferred stock then in effect
plus (2)&nbsp;any accrued but unpaid dividends on the Series&nbsp;3 5%
preferred stock plus (3)&nbsp;any unpaid liquidated damages or other amounts
payable to the holders of the Series&nbsp;3 5% preferred stock. The redemption
price for the shares of Series&nbsp;2 5% preferred stock equals the sum of (1)&nbsp;the
greater of $3.25 and the volume weighted average price of our common stock on
the trading day immediately preceding the redemption event multiplied by $2.50
divided by the conversion price of the Series&nbsp;2 5% preferred stock then in
effect plus (2)&nbsp;any accrued but unpaid dividends on the Series&nbsp;2 5%
preferred stock plus (3)&nbsp;any unpaid liquidated damages or other amounts
payable to the holders of the Series&nbsp;2 5% preferred stock. As a result,
assuming we have paid all liquidated damages and other amounts to the holders, accrued
but unpaid dividends on January&nbsp;13, 2006 of $14,445, a volume weighted
average price of $1.90, which was the ten-day weighted average closing price of
our common stock on December&nbsp;30, 2005, and our 6,909,507 shares of common
stock outstanding on January&nbsp;13, 2006, we would issue approximately
2,273,362 shares of our common stock if a specified redemption event occurs and
all holders of Series&nbsp;3 5% preferred stock and Series&nbsp;2 5% preferred
stock elected to redeem their shares for common stock. This would represent an
increase of approximately 32.9% in the number of shares of our common stock as
of January&nbsp;13, 2006.</font></p>

<p style="font-style:italic;font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:0pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">The conversion of
preferred stock or exercise of warrants we issued in our recent private
placements may cause the price of our common stock to decline.</font></i></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The holders of the shares of 5% preferred stock and
warrants we issued on March&nbsp;25, 2004, and the holders of the shares of Series&nbsp;2
5% preferred stock and warrants we issued on March&nbsp;28, 2005, may freely
convert their shares of preferred stock and exercise their warrants and sell
the underlying shares of common stock pursuant to effective registration
statements we filed with the SEC. As of January&nbsp;13, 2006, 740,304 shares
of 5% preferred stock had converted into 1,177,327 shares of common stock, and
565,200 shares of Series&nbsp;2 5% preferred stock had converted into 565,200
shares of common stock. In addition, upon the effectiveness of the registration
statement related to this prospectus, the investors in our December&nbsp;2,&nbsp;2005,
private placement would be able to freely sell the shares of common stock
underlying their shares of Series&nbsp;3 5% preferred stock and warrants we
issued to them in that private placement upon the conversion of their shares
and exercise of their warrants.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the four weeks ended
on January&nbsp;13, 2006, the average daily trading volume of our common stock
on The Nasdaq Capital Market was 24,450 shares. Consequently, if holders of
preferred stock or warrants elect to convert their remaining shares or exercise
their warrants and sell a material amount of their underlying shares of common
stock on the open market, the increase in selling activity could cause a
decline in the market price of our common stock. Furthermore, these sales, or
the potential for these sales, could encourage short sales, causing additional
downward pressure on the market price of our common stock.</font></p>

<p style="font-style:italic;font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">The payment of accrued dividends on our preferred
stock may strain our cash resources.</font></i></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shares of our 5% preferred stock accrue cash dividends
equal to $0.25 per share per annum, payable in arrears on March&nbsp;31 and September&nbsp;30
of each year, shares of our Series&nbsp;2 5% preferred stock accrue </font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">4</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='4',FILE='C:\fc\1892815317_D11188_754376\2791-1-dc.htm',USER='jmsproofassembler',CD='Jan 18 09:28 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">cash dividends equal to
$0.125 per share per annum, payable in arrears on the first business day of
March, June, September&nbsp;and December&nbsp;of each year and shares of our Series&nbsp;3
5% preferred stock accrue cash dividends equal to $0.109 per share per annum,
payable in arrears on the first business day of March, June, September&nbsp;and
December&nbsp;of each year. The amount of the dividends on our Series&nbsp;2 5%
preferred stock may increase to $0.45 per share per annum and the amount of the
dividends on our Series&nbsp;3 5% preferred stock may increase to $0.3294 per
share per annum upon the occurrence of certain event entitling the holders of
these shares to redemption.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During 2004, we paid $129 thousand in dividends
related to our 5% convertible preferred stock and at January&nbsp;13, 2006, we
have dividends accrued of $18,499 related to our 5% preferred stock, $7,363
related to our Series&nbsp;2 5% preferred stock and $7,082 related to our Series&nbsp;3
5% preferred stock.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Delaware law provides that we may only pay dividends
out of our capital surplus or, if no surplus is available, out of our net
profits for the fiscal year the dividend is declared and/or the preceding fiscal
year. We have not had net profits for the last two fiscal years ended as of December&nbsp;31,
2004. However, we did have sufficient capital surplus, defined as the amount by
which our net assets exceed our stated capital, based on par value of our
outstanding shares as provided by Delaware law. Although we are currently able
to pay accrued dividends on our outstanding shares of preferred stock, we
cannot assure you that our net assets will continue to exceed our stated
capital or that we will have net profits in order to pay these dividends in the
future. These dividends continue to accrue on our outstanding shares of
preferred stock, regardless of whether we are legally able to pay them. The
accrual of these dividends may adversely affect our operating results. Moreover,
the payment of these dividends could strain our available cash resources, which
could adversely affect our ability to operate or grow our business.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, our inability
to pay dividends could require us to redeem outstanding shares of Series&nbsp;2
5% preferred stock and Series&nbsp;3 5% preferred stock for shares of our
common stock issued at a price equal to 75% of the average of the volume
weighted average price of our common stock for the ten days ending on the day
immediately preceding an election to redeem, subject, in the case of the Series&nbsp;3
5% preferred stock, to a floor of $0.87. As a result, the issuance, or
potential issuance, of these additional shares of common stock could cause our
stock price to decline. Furthermore, our inability to pay dividends could
adversely affect our ability to raise equity financing in the future if
required.</font></p>

<p style="font-style:italic;font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our management may spend the proceeds of this offering
in ways with which you do not agree.</font></i></b></p>

<p style="margin:0pt 0pt 18.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our management will have
broad discretion over how we use the net proceeds of this offering and could
spend proceeds in ways with which you do not agree. Pending deployment of the
funds, the proceeds may be invested in ways that do not yield favorable returns.
Please see the &#147;<i><font style="font-style:italic;">Use of Proceeds</font></i>&#148; section of this
prospectus for information about how we plan to use the proceeds of this
offering.</font></p>

<div style="line-height:9.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">5</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='5',FILE='C:\fc\1892815317_D11188_754376\2791-1-dc.htm',USER='jmsproofassembler',CD='Jan 18 09:28 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="NoteRegardingForwardlookingStatem_202828"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></b></p>

<p style="margin:0pt 0pt 18.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This prospectus and the
materials incorporated herein by reference contain forward-looking statements
that involve substantial risks and uncertainties. You can identify these
statements by forwarding-looking words such as &#147;may,&#148; &#147;will,&#148; &#147;expect,&#148; &#147;intend,&#148;
&#147;anticipate,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;continue&#148; and other similar words. You
should read statements that contain these words carefully because they discuss
our future expectations, make projections of our future results of operations
or of our financial condition or state other &#147;forward-looking&#148; information. We
believe that it is important to communicate our future expectations to our
investors. However, there may be events in the future that we are not able to
accurately predict or control. Our actual results could differ materially from
the expectations we describe in our forward-looking statements as a result of
certain factors, as more fully described in the &#147;Risk Factors&#148; section of this
prospectus and the section entitled &#147;Factors That May Affect Future Results of
Operations&#148; and elsewhere in the documents we file with the SEC that are
incorporated herein.</font></p>

<div style="line-height:9.0pt;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">6</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='6',FILE='C:\fc\17223731283_D11389_753616\2791-1-de.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="DescriptionOfSecuritiesAndRelated_202939"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">DESCRIPTION OF SECURITIES AND RELATED TRANSACTIONS</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="PrivatePlacement_202828"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Private Placement</font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On December&nbsp;2, 2005, we completed a private
placement under Rule&nbsp;506 of Regulation D with six institutional investors
and three individual accredited investors, including G. Ward Paxton, our
Chairman, President and Chief Executive Officer, and James F. Gero, a member of
our Board of Directors, pursuant to which the investors paid us an aggregate of
$1,230,842.92 in consideration for (1)&nbsp;564,607 shares of our Series&nbsp;3
5% convertible preferred stock convertible into shares of our common stock at
an initial conversion price of $2.18 per share and (2)&nbsp;warrants to
purchase up to 282,306 shares of our common stock at an initial exercise price
of $2.58 per share.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As a condition to the
consummation of the private placement, each of our officers and directors
executed a voting agreement pursuant to which they have agreed to vote the
shares owned by them in favor of any proposal to stockholders requesting an
approval of the issuance of more then 1,381,900 shares of our common stock,
which represents 19.999% of our common stock outstanding as of December&nbsp;2,
2005, upon conversion of the shares of preferred stock and the exercise of the
warrants we issued in this private placement, to the extent this approval is
required by Nasdaq rules.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="CompensationOfPlacementAgent_202828"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compensation of Placement Agent</font></b></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stonegate
Securities,&nbsp;Inc. acted as our placement agent for this private placement. As
compensation for services rendered to us by Stonegate, we agreed to:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>pay
Stonegate a cash fee equal to $60,016.80, including a $5,000 retainer fee; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>issue
to Stonegate or its assigns warrants to purchase an aggregate of 27,531 shares
of our common stock at an&#160; exercise price
of $2.58 per share.</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We issued the warrants to
two affiliates of Stonegate pursuant to Rule&nbsp;506 of Regulation D.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="TermsOfTheSeries35ConvertiblePref_202829"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Terms
of the Series&nbsp;3 5% Convertible Preferred Stock</font></b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dividends.</font></i></font>&nbsp;&nbsp; Holders
of the Series&nbsp;3 5% preferred stock are entitled to a 5% per annum dividend
per share. The dividend accrues and is payable in cash quarterly on the first
business day of March, June, September&nbsp;and December&nbsp;of each year,
beginning on March&nbsp;1, 2006. Dividends may increase to 18% per annum upon
the occurrence of certain redemption events described below under &#147;<i><font style="font-style:italic;">Terms of the Series&nbsp;3 5% Convertible Preferred
Stock&#151;Redemption</font></i>.&#148;</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accrued but unpaid dividends are payable upon the
conversion or redemption of the shares of preferred stock and upon a
liquidation event. Dividends not paid within five business days of the day they
are due accrue daily interest at the lesser of 18% per annum or the maximum
rate permitted by law, until the dividends and the accrued interest are paid in
cash.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As long as any shares of the Series&nbsp;3 5%
preferred stock are outstanding, we cannot pay dividends or make other
distribution on, redeem shares of, or set money aside or create a sinking fund
for that purpose for, any shares of capital stock ranking junior to the Series&nbsp;3
5% preferred stock with respect to dividends, including our common stock. However,
this restriction does not apply to the payment of accrued dividends on our
existing 5% preferred stock and Series&nbsp;2 5% preferred stock or the
conversion of any of our convertible capital stock in accordance with its
terms.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">7</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='7',FILE='C:\fc\17223731283_D11389_753616\2791-1-de.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Voting Rights.</font></i></font>&nbsp;&nbsp; Holders
of the preferred stock have no voting rights, except as required by law. However,
as long as any shares of the Series&nbsp;3 5% preferred stock remain
outstanding, we cannot take any of the following actions without the separate
class vote or written consent of at least 75% of the then outstanding shares of
the Series&nbsp;3 5% preferred stock:</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>alter
or change adversely the powers, preferences or privileges of the Series&nbsp;3
5% preferred stock;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>alter
or amend the Certificate of Designation creating the Series&nbsp;3 5% preferred
stock;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>authorize
or create any class stock ranking senior to, or on an equal basis with, the Series&nbsp;3
5% preferred stock with respect to dividends, redemption or liquidation;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>amend
our certificate of incorporation, bylaws or other organizational documents in a
manner which adversely affects the rights of any of the holders of the Series&nbsp;3
5% preferred stock;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>increase
the authorized number of shares of the Series&nbsp;3 5% preferred stock; or</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>enter
into any agreement to do any of the above.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conversion.</font></i></font>&nbsp;&nbsp; The
holders of the Series&nbsp;3 5% preferred stock have the option to convert
their shares into shares of our common stock at an initial conversion price of
$2.18 per share. We also have the right to force conversion of outstanding
shares of the Series&nbsp;3 5% preferred stock after December&nbsp;2, 2006, if
the following conditions are met:</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
volume weighted average price of our common stock must be at least 200% of the
conversion price of the preferred stock then in effect, for a period of 20
consecutive trading days immediately preceding the redemption;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>we
notify the holders of the conversion within one trading day after our common
stock meets the above trading price requirement;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>we
have honored all requested conversions of the Series&nbsp;3 5% preferred stock,
if any;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>we
have paid any liquidated damages or other amounts owing on the Series&nbsp;3 5%
preferred stock;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
registration statement related to this prospectus is effective and is expected
to remain effective;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
common stock is traded on The Nasdaq Capital Market, The Nasdaq National
Market, the New York Stock Exchange, the American Stock Exchange or the OTC
Bulletin Board;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>we
have a sufficient number of authorized but unissued shares of our common stock
to permit the conversion;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>no
event which would give the holders the right to redeem their shares has
occurred;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
issuance of the shares of common stock would not cause a relevant holder to
exceed the 4.99% beneficial ownership limitation described below; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>we
have not publicly announced any merger or consolidation, sale of all or
substantially all of our assets, tender or exchange offer, reclassification of
our common stock or any share exchange or any transaction which would
constitute a change of control for purposes of the liquidation preference of
the Series&nbsp;3 5% preferred stock.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Because the original purchase price and the initial
conversion price are the same, each share of Series&nbsp;3 5% preferred stock
is initially convertible into one share of our common stock. The Series&nbsp;3
5% preferred stock contains adjustment provisions upon the occurrence of stock
splits, stock dividends, combinations, reclassifications or similar events of
our capital stock as well as any rights offering or pro rata distribution of
cash, property, assets or securities to holders of our common stock.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">8</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='8',FILE='C:\fc\17223731283_D11389_753616\2791-1-de.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A holder of Series&nbsp;3 5% preferred stock cannot
convert their shares into shares of our common stock if that holder would
beneficially own greater than 4.99% of our issued and outstanding shares of
common stock, as determined in accordance with Section&nbsp;13(d)&nbsp;of the
Exchange Act, upon conversion. However, this restriction does not apply to any
holder of Series&nbsp;3 5% preferred stock who is one of our directors or
officers. Although this restriction does not limit the conversion of the shares
of Series&nbsp;3 5% preferred stock purchased by Mr.&nbsp;Paxton or Mr.&nbsp;Gero,
neither Mr.&nbsp;Paxton nor Mr.&nbsp;Gero may convert their shares into common
stock unless and until the issuance is approved by our stockholders to the
extent required by Nasdaq rules.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, we cannot issue shares to a holder of Series&nbsp;3
5% preferred stock if the number of shares issuable upon conversion of all
shares of Series&nbsp;3 5% preferred stock added together with the number of
shares issuable upon the exercise of the private placement warrants exceeds
1,381,900 shares, or 19.999% of our outstanding shares of common stock on December&nbsp;2,
2005, unless we have received the requisite approval of our stockholders under
Nasdaq Marketplace Rule&nbsp;4350.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rank;
Liquidation Preference.</font></i></font>&nbsp;&nbsp; The holders of Series&nbsp;3
5% preferred stock rank prior to the holders of our common stock, existing 5%
preferred stock and existing Series&nbsp;2 5% preferred stock with respect to
the distribution of our assets upon a dissolution, liquidation or other similar
event. The liquidation preference for the Series&nbsp;3 5% preferred stock is
an amount equal to $2.18 per share plus any accrued but unpaid dividends.</p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition to a
dissolution, liquidation or similar event, the following &#147;change of control&#148;
transactions constitute a liquidation:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>an
acquisition by an individual, legal entity or group, as defined in Rule&nbsp;13d-5(b)(1)&nbsp;of
the Exchange Act of 1934, as amended, of more than 33% of our voting
securities;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>a
merger or consolidation with or into another entity, after which our
stockholders own less than 66% of the aggregate voting power of the surviving
corporation;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>a
sale of all or substantially all of our assets to an entity in which our
stockholders own less than 66% of aggregate voting power of the acquiring entity;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>a
replacement at one time or within one year of more than half the members of our
board of directors which is not approved by the members of our board of
directors or their nominees; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
execution of a binding agreement to effect any of the above transactions.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Redemption.</font></i></font>&nbsp;&nbsp; Holders
of Series&nbsp;3 5% preferred stock can require us to redeem all of their
shares of upon the occurrence of any of the following events:</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
failure of the registration statement relating to this prospectus to be
declared effective by the SEC by July&nbsp;20, 2006;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
registration statement ceases to be effective or a holder is not permitted to
resell its shares of common stock registered for resale for more than 90
calendar days in any twelve month period;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
failure to deliver certificates for common stock within 10 trading days of a
request to convert, or we publicly announce that we will not comply with
requests to convert;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
failure to pay a holder for any damages that holder incurs as a result of open
market purchases to cover sales of common stock for which we did not timely
issue common stock certificates on conversion within ten days after receipt of
notice of the damages from that holder;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
failure to have a sufficient number of authorized but unissued shares of our
common stock to permit conversion;</p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">9</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='9',FILE='C:\fc\17223731283_D11389_753616\2791-1-de.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
breach of any representation, warranty, covenant or agreement in the Securities
Purchase Agreement, Registration Rights Agreement, warrants or other
transaction documents executed in connection with the private placement which
we have not cured within 45 days after notice of such breach;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
redemption of any shares of common stock, existing 5% preferred stock or
existing Series&nbsp;2 5% preferred stock, other than conversions of the
existing 5% preferred stock and Series&nbsp;2 5% preferred stock and the
repurchase of up $100,000 per calendar year of common stock from employees,
officers, directors, consultants and other service providers upon their
termination;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>we
become party to a change of control transaction that results in a liquidation
of the Series&nbsp;3 5% preferred stock; or</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>we
have filed for bankruptcy, whether voluntarily or involuntarily, or made a
general assignment for the benefit of creditors.</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The redemption price is
the sum of (1)&nbsp;the greater of $2.834 and the product of the volume
weighted average price of our common stock on the trading day immediately
preceding the event multiplied by $2.18 divided by the conversion price then in
effect plus (2)&nbsp;any accrued but unpaid dividends on the Series&nbsp;3 5%
preferred stock plus (3)&nbsp;all liquidated damages or other amounts payable
to the holders of Series&nbsp;3 5% preferred stock. The redemption price is
payable in cash if a redemption event occurs as a result of our failure to
deliver stock certificates upon conversion, our public announcement of our
refusal to comply with conversion requests, our failure to pay damages to a
holder who is forced to cover a sale for which we did not timely issue
certificates, our breach of the provisions of any of the agreements executed in
connection with the private placement, our becoming party to a change of
control transaction or our voluntary bankruptcy. In the case of any other
redemption event, a holder has the option to receive a number of shares of our
common stock equal to the redemption price divided by 75% of the ten-day
average of the volume weighted average price of our common stock ending on the
day immediately preceding the holder&#146;s election, subject to a floor of $0.87
per share, or an increase in the dividends payable per share to 18% per annum.
Mr.&nbsp;Paxton and Mr.&nbsp;Gero will not be able to receive stock upon
redemption of their shares unless and until the issuance is approved by our
stockholders to the extent required by Nasdaq rules. Payment of the redemption
price is due within five trading days after the holder provides us with a
notice of payment, after which the unpaid amount accrues interest daily at a
rate equal to the lower of 18% per annum and the highest rate permitted by law.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="TermsOfTheWarrants_202832"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Terms of the Warrants</font></b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Private
Placement Warrants.</font></i></font>&nbsp;&nbsp; The warrants we issued in
the private placement have an initial exercise price of $2.58 per share and are
exercisable for our common stock at any time during the period commencing on June&nbsp;2,
2006 and ending on or before June&nbsp;2, 2011. The warrants contain a cashless
exercise provision, permitting the holder at any time on or after December&nbsp;2,
2007, in lieu of paying the exercise price, to surrender the warrant for a
number of shares of common stock determined by multiplying the number of shares
of common stock underlying the warrant by a fraction based on the exercise
price of the warrant and the volume weighted average price of our common stock
on trading day immediately preceding the exercise date. A holder may only use
the cashless exercise if there is no effective registration statement covering
the resale of the shares of common stock underlying the warrant at the time the
holder wishes to exercise.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All of the warrants contain adjustment provisions upon
the occurrence of stock splits, stock dividends, combinations, reclassification
or similar events of our capital stock as well as pro rata distributions of
cash, property, assets or securities to holders of our common stock. In
addition, if we issue shares of common stock or securities convertible into or exercisable
for shares of common stock at a price less than the exercise price of the
warrants, other than an issuance exempt from the purchasers&#146; pre-emptive rights
</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">10</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='10',FILE='C:\fc\17223731283_D11389_753616\2791-1-de.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">described below under &#147;<i><font style="font-style:italic;">Pre-emptive Rights and Restrictions on Future Sales
of Equity&#151;Pre-emptive Rights</font></i>,&#148; the exercise price of the warrants
will reset to the lower price.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A holder of a warrant cannot exercise warrants for
shares of our common stock if that holder would beneficially own greater than
4.99% of our issued and outstanding shares of common stock, as determined in
accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act, upon exercise of
the warrants. However, this restriction does not apply to any holder of a
warrant who is one of our directors or officers. Although this restriction does
not currently limit the exercise of the warrants acquired by Mr.&nbsp;Paxton or
Mr.&nbsp;Gero, neither Mr.&nbsp;Paxton or Mr.&nbsp;Gero may exercise their
warrants for common stock unless the issuance is approved by our stockholders
to the extent required by Nasdaq rules.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, we cannot issue shares of common stock
upon the exercise of a warrant if the number of shares to be issued upon the
exercise of all of the private placement warrants added together with the
number of shares issuable upon the conversion of the Series&nbsp;3 5% preferred
stock, exceeds 1,381,900, or 19.999% of our outstanding shares of common stock
on December&nbsp;2, 2005, unless we have received the requisite approval of our
stockholders under Nasdaq Marketplace rule&nbsp;4350.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stonegate
Warrants.</font></i></font>&nbsp;&nbsp; The warrants we issued to the
affiliates of Stonegate have an initial exercise price of $2.58 per share and
are exercisable for our common stock at any time on or before December&nbsp;2,
2011. Each warrant contains a cashless exercise provision, permitting the
holder, in lieu of paying the exercise price, to surrender the warrant for a
number of shares of common stock determined by multiplying the number of shares
of common stock underlying the warrant by a fraction based on the exercise
price of the warrant and the current market value of our common stock.</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The warrants contain
adjustment provisions upon the occurrence of stock splits, stock dividends,
combinations, reclassification or similar events of our capital stock.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="PreemptiveRightsAndRestrictionsOn_202832"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pre-emptive
Rights and Restrictions on Future Sales of Equity</font></b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pre-emptive
Rights.</font></i></font>&nbsp;&nbsp; Pursuant to the terms of the Securities
Purchase Agreement entered into in connection with the private placement, we
granted the investors, other than Mr.&nbsp;Paxton and Mr.&nbsp;Gero, who
continue to own shares of preferred stock prior to the sale, the right to
purchase up to 100% of the securities we may offer in certain future sales of
securities within 180 days of the effective date of the registration statement
relating to this prospectus.</p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The investors&#146;
right of purchase will not apply to the following issuances by us:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>shares
issuable upon the conversion of the Series&nbsp;3 5% preferred stock or the
exercise of the warrants;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>securities
we issue to directors, officers, employees and consultants as compensation;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>securities
issuable upon the exercise of options, warrants or other convertible securities
currently outstanding, as long as we have not amended these securities to
increase the number of shares issuable upon conversion or to decrease the
exercise price other than as a result of their respective anti-dilution
provisions;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>shares
of stock issued in connection with a stock split, stock dividend or
recapitalization;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>securities
we issue in connection with commercial lending and lease transactions;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>securities
we issue as compensation to registered broker-dealers engaged by us to obtain
financing on our behalf;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>securities
we issue in connection with acquisitions or strategic transactions; and</p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">11</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='11',FILE='C:\fc\17223731283_D11389_753616\2791-1-de.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>shares
of stock we issue in a firm commitment, underwritten public offering with gross
proceeds of at least $30,000,000.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Restrictions
of Future Sales.</font></i></font>&nbsp;&nbsp; The Securities Purchase
Agreement also restricts us from issuing any shares of common stock or other
securities convertible or exercisable for common stock until the date that is
180 days after the effective date of the registration statement relating to this
prospectus. In addition, as long as any investor holds Series&nbsp;3 5%
preferred stock or warrants, we cannot issue debt or equity securities that are
convertible or exercisable for shares of common stock at a price that varies
with the trading price of our common stock or is subject to reset for events
contingent on our business or the price of our common stock or enter into any
other agreement, including an equity line of credit, pursuant to which we sell
securities at a future determined price. However, these restrictions do not
apply to transactions which are exempt from the pre-emptive rights described
above.</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">These provisions may
hinder or delay our ability to raise additional debt or equity financing if and
when we require additional capital to operate or grow our business.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="RegistrationRights_202834"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registration Rights</font></b></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In connection with
the Securities Purchase Agreement, we entered into a Registration Rights
Agreement, pursuant to which we are required to file a registration statement
to register the 846,913 shares of common stock issuable upon the conversion of
the preferred stock and upon the exercise of the warrants issued to the
investors in the private placement. This prospectus relates to the registration
of all of these shares of common stock. Under the terms of the Registration
Rights Agreement, we may be subject to the payment of partial liquidated
damages if any of the following events occurs:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
registration statement relating to this prospectus is not declared effective by
the SEC by the earlier to occur of January&nbsp;6, 2006 or the fifth trading
day after the SEC informs us that they have no further review of the
registration statement;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>we
fail to request acceleration of the registration statement relating to this
prospectus within five trading days of the SEC informing us they have no
further review of the registration statement or to file a pre-effective
amendment to the registration statement within ten trading days after receiving
any SEC comments; or</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
registration statement ceases to be effective or a holder is not permitted to
resell its shares of common stock registered for resale for more than 30
calendar days in any twelve month period.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The amount of liquidated damages will equal 1% of the
aggregate purchase price paid to us by the investors in the private placement
for the first thirty-day period, and 2% of the aggregate purchase price for
each subsequent thirty-day period, each pro rated for any shorter period,
following any of the above events. The damages are payable on the monthly
anniversary of the date of the event giving rise to the damages. Any damages
not paid within seven days of the date due will accrue daily interest at the
lesser of 18% per annum and the maximum amount permitted by law until paid in
full. No damages are payable to the affiliates of Stonegate with respect to the
shares of common stock underlying the warrants we issued to them or to any
person who is one of our officers or directors at the time the payment is due.
Therefore, Mr.&nbsp;Paxton and Mr.&nbsp;Gero are not currently entitled to
receive any of these damages.</font></p>

<p style="margin:0pt 0pt 18.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We must keep the
registration statement related to this prospectus effective until the earlier
to occur of the date when all the securities covered by the registration
statement may be sold without restriction pursuant to Rule&nbsp;144(k)&nbsp;and
the date on which all securities covered by the registration statement have
been sold.</font></p>

<div style="line-height:9.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">12</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='12',FILE='C:\fc\17223731283_D11389_753616\2791-1-de.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="PlanOfDistribution_204227"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">PLAN OF DISTRIBUTION</font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shares of our common stock held by the selling
stockholders and covered by this prospectus may be sold or distributed at any
time or from time to time by the selling stockholders, their pledgees, donees,
transferees or other successors in interest, in one or more transactions. The
selling stockholders will act independently of us in making decisions with
respect to the timing, manner and size of each sale. The selling stockholders
may sell their shares at market prices prevailing at the time of sale, at
prices related to the then current market price, at varying prices determined
at the time of sale in negotiated transactions, or at such other price as the
selling stockholders may determine from time to time.</font></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The selling
stockholders may offer their shares at various times in one or more of, or a
combination of, the following or other kinds of transactions:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>transactions
on any national securities exchange or U.S. inter-dealer system of a registered
national securities association on which the common stock may be listed or
quoted at the time of sale;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>in
the over-the-counter market;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>in
private transactions and transactions otherwise than on these exchanges or
systems or in the over-the-counter market;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>in
connection with short sales of the shares entered into after the effective date
of the registration statement of which this prospectus is a part;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>by
pledge to secure or in payment of debt and other obligations;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>block
trades in which the broker-dealer will attempt to sell the shares as agent but
may position and resell a portion of the block as principal to facilitate the
transaction;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>purchases
by a broker-dealer as principal and resale by the broker-dealer for its
account;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>broker-dealers
may agree with the selling stockholders to sell a specified number of such
shares at a stipulated price per share;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>through
the writing of options, whether the options are listed on an options exchange
or otherwise; or</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>in
connection with the writing of non-traded and exchange-traded call options, in
hedge transactions and in settlement of other transactions in standardized or
over-the-counter options.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No selling stockholder had any agreement or
understanding, directly or indirectly, with any person to distribute the shares
underlying the preferred stock and warrants at the time the selling stockholder
purchased them. All of the selling stockholders purchased the securities in the
ordinary course of business.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If the selling stockholders effect these transactions
by selling shares to or through broker-dealers or agents, those broker-dealers
or agents may receive compensation in the form of commissions, discounts or
concessions from selling stockholders or commissions from purchasers of the
shares for whom they may act as agent. These commissions, discounts or
concessions as to a particular broker-dealers or agents may be in excess of
customary commissions in the types of transactions involved. Broker-dealers or
agents and any other participating broker-dealers or the selling stockholders
may be deemed to be &#147;underwriters&#148; within the meaning of Section&nbsp;2(11) of
the Securities Act in connection with sales of the shares. Because selling
stockholders may be deemed to be &#147;underwriters&#148; within the meaning of Section&nbsp;2(11)
of the Securities Act, the selling stockholders will be subject to the
prospectus delivery requirements of the Securities Act. The selling
stockholders have not entered into any agreements, understandings or
arrangements with any underwriters or broker-dealers with respect to the sale
of the shares covered by this prospectus.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">13</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='13',FILE='C:\fc\17223742315_D11389_753616\2791-1-dg.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The selling stockholders may enter into hedging
transactions with broker-dealers or other financial institutions in connection
with distributions of the shares or otherwise. In these transactions,
broker-dealers or other financial institutions may engage in short sales of the
shares in the course of hedging the positions they assume with selling
stockholders. The selling stockholders also may sell shares short and redeliver
the shares to close out short positions. Several of the selling stockholders
have entered into short positions as of the date hereof. None of the shares
issuable upon conversion of the preferred stock or exercise of the warrants and
none of the other shares described in this prospectus will be used to cover any
of these short positions or any other short positions prior to the
effectiveness of the registration statement relating to this prospectus. The
selling stockholders may enter into option or other transactions with
broker-dealers or other financial institutions which require the delivery to
the broker-dealer or financial institutions of the shares. The broker-dealer or
other financial institutions may then resell or otherwise transfer those shares
pursuant to this prospectus.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The selling stockholders also may loan or pledge the
shares to a broker-dealer. The broker-dealer or other financial institutions
may sell the shares so loaned, or upon a default the broker-dealer may sell the
pledged shares pursuant to this prospectus.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under the securities laws of certain states, the
shares may be sold in those states only through registered or licensed brokers
or dealers. In addition, in certain states the shares may not be sold unless
they have been registered or qualified for sale in the applicable state or an
exemption from the registration or qualification requirement is available and
is complied with.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Selling stockholders may also resell all or a portion
of the shares in open market transactions in reliance upon Rule&nbsp;144 under
the Securities Act, rather than under this prospectus, provided they meet the
criteria and conform to the requirements of such rule.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under applicable rules&nbsp;and regulations under the
Exchange Act, any person engaged in the distribution of the shares may not
simultaneously engage in market making activities with respect to our common
stock until his or her participation in that distribution is completed. In
addition, each selling stockholder will be subject to applicable provisions of
the Exchange Act and the associated rules&nbsp;and regulations under the
Exchange Act, including Regulation M, which provisions may limit the timing of
purchases and sales of shares of common stock by the selling stockholders.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We will make copies of this prospectus available to
the selling stockholders. We have informed them of the need for delivery of
copies of this prospectus to purchasers at or prior to the time of any sale of
the shares offered hereby. The selling stockholders may agree to indemnify any
broker-dealer or agent that participates in transactions involving sales of the
shares against certain liabilities, including liabilities under the Securities
Act.</font></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">At the time a
particular offer of shares is made, we will file a supplement to this
prospectus, if required, that will disclose:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
name of each such selling stockholder and of the participating
broker-dealer(s);</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
number of shares involved;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
price at which such shares were sold;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
commissions paid or discounts or concessions allowed to such broker-dealer(s),
where applicable;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>that
such broker-dealer(s)&nbsp;did not conduct any investigation to verify the
information set out or incorporated by reference in this prospectus; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>other
facts material to the transaction.</p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">14</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='14',FILE='C:\fc\17223742315_D11389_753616\2791-1-dg.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, upon being notified by a selling
stockholder that a donee or pledgee intends to sell more than 500 shares, we
will file a supplement to this prospectus.</font></p>

<p style="margin:0pt 0pt 18.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We entered into the
registration rights agreement described under &#147;<i><font style="font-style:italic;">Description
of Securities and Related Transactions&#151;Registration Rights</font></i>&#148; for the
benefit of the selling stockholders to register the shares of common stock
under applicable federal and state securities laws. Pursuant to the terms of
the registration rights agreement, we will pay all expenses of the registration
of the shares except that the selling stockholders will pay any applicable
commissions and discounts attributable to the sales of the shares and costs and
expenses of their own counsel. We have agreed to indemnify the selling
stockholders against certain liabilities relating to the registration
statement, including liabilities under the Securities Act. Conversely, each
selling stockholder has agreed to indemnify us against certain liabilities
relating to the information given to us in writing by that selling stockholder
for inclusion in the registration statement, including liabilities under the
Securities Act.</font></p>

<div style="line-height:9.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">15</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='15',FILE='C:\fc\17223742315_D11389_753616\2791-1-dg.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="UseOfProceeds_223434"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">USE OF PROCEEDS</font></b></p>

<p style="margin:0pt 0pt 18.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We will receive the
exercise price of the warrants, if they are exercised for cash, but will
receive no proceeds from the resale of the underlying shares which may be
offered hereby. As of the date of this prospectus, if all of the warrants for
which we are registering the underlying shares of our common stock are
exercised for cash, we would receive an aggregate of approximately $799,379.46.
We intend to use the proceeds, if any, from the exercise of the warrants for
general corporate purposes and working capital.</font></p>

<div style="line-height:9.0pt;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">16</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='16',FILE='C:\fc\17223743186_D11389_753616\2791-1-di.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="SellingStockholders_213332"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">SELLING STOCKHOLDERS</font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table identifies each of the selling
stockholders and sets forth information as of the date of this prospectus with
respect to the number of shares which may be offered under this prospectus from
time to time by each selling stockholder. This information includes shares
obtainable upon conversion or exercise of shares of preferred stock and
warrants, which are currently convertible or exercisable into shares of our
common stock. Except as otherwise indicated, the persons named in the table
below have sole investment and voting power with respect to all shares
beneficially owned, subject to community property laws, where applicable. Percentage
ownership is based on 6,909,507 shares of our common stock outstanding on January&nbsp;13,
2006. For purposes of this table, the shares of common stock beneficially owned
by a person or group of persons before the offering equals the sum of:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>any
shares beneficially owned unrelated to the Series&nbsp;3 5% preferred stock and
warrants, including any shares that person or group has the right to acquire
within 60 days;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
shares beneficially owned underlying the Series&nbsp;3 5% preferred stock based
on a conversion price of $2.18;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
shares beneficially owned underlying the warrants based on an exercise price of
$2.58; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>in
calculating the percentage for each selling stockholder, the shares issuable
upon conversion of the Series&nbsp;3 5% preferred stock and exercise of the
warrants for any selling stockholder are included in the denominator of the
shares outstanding for that selling stockholder but are not included in the
denominator for any other person.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under the terms of the Series&nbsp;3 5% preferred
stock and warrants we issued in the private placement, the shares of Series&nbsp;3
5% preferred stock are convertible and the warrants are exercisable by any
selling stockholder who participated in the private placement only to the
extent that the number of shares of common stock issuable pursuant to those
securities, together with the number of shares of our common stock owned by
that selling stockholder and its affiliates (but not including shares of common
stock underlying unconverted portions of the Series&nbsp;3 5% preferred stock
or unexercised portions of the warrants) would not exceed 4.99% of the then
outstanding common stock as determined in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act. However, this restriction does not apply to any holder of Series&nbsp;3
5% preferred stock or warrants who is one of our directors or officers. Although
this restriction does not currently limit the conversion of shares or the
exercise of warrants by Mr.&nbsp;Paxton or Mr.&nbsp;Gero, neither Mr.&nbsp;Paxton
nor Mr.&nbsp;Gero may convert their shares into, or exercise their warrants
for, common stock unless the issuance is approved by our stockholders to the
extent required by NASDAQ rules. In addition, we cannot issue shares of common
stock to any selling stockholder who participated in the private placement upon
the conversion of their shares or the exercise of their warrants if the number
of shares to be issued upon the conversion of all of the shares of Series&nbsp;3
5% preferred stock and all of the warrants we issued in the private placement
exceeds 1,381,900, or 19.99% of our outstanding shares of common stock on December&nbsp;2,
2005, unless we have received the requisite approval of our stockholders under
Nasdaq Marketplace Rule&nbsp;4350. Finally, the selling stockholders who
participated in the private placement may not exercise their warrants until June&nbsp;2,
2006. Accordingly, the number of shares of common stock set forth in the
columns &#147;Shares Beneficially Owned Before Offering&#148; and &#147;Shares Offered&#148; in the
table below for certain selling stockholders may exceed the number of shares of
common stock that the selling stockholder could beneficially own at any given
time through the ownership of their shares or Series&nbsp;3 5% preferred stock
or warrants.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All of the shares of common stock being offered by
this prospectus are being offered by the selling stockholders for their own
accounts. Because the selling stockholders may sell all, some or none of the
shares covered by this prospectus, and there are currently no agreements,
arrangements or understandings with any of the selling stockholders with
respect to the sale of any of the shares, we cannot estimate the </font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">17</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='17',FILE='C:\fc\17223743186_D11389_753616\2791-1-di.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">number of shares or the
percentage of outstanding shares of common stock, that will be held by any of
them upon termination of this offering. For purposes of this table, we are
assuming that the selling stockholders will sell all of the shares offered by
this prospectus and will not acquire any additional shares.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This prospectus also covers any additional shares of
common stock which may become issuable in connection with shares sold by reason
of a stock dividend, stock split, recapitalization or other similar transaction
effected without us receiving any cash or other value, which results in an
increase in the number of our outstanding shares of common stock.</font></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Of the 874,444
shares of common stock being offered by the selling stockholders:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>846,913
shares are issuable upon conversion of the Series&nbsp;3 5% preferred stock and
the exercise of the warrants purchased by the investors in the private
placement described under &#147;<i><font style="font-style:italic;">The Transactions&#151;Private
Placement&#148; </font></i>and <i><font style="font-style:italic;">&#147;Description of
Securities and Related Transactions&#151;Private Placement</font></i>;&#148; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>27,531
shares are issuable upon the exercise of the warrants we issued to two
affiliates of Stonegate Securities,&nbsp;Inc., for acting as our placement
agent in the private placement; see &#147;<i><font style="font-style:italic;">The
Transactions&#151;Compensation of Placement Agent</font></i>,&#148; &#147;<i><font style="font-style:italic;">Description of Securities and Related Transactions&#151;Compensation
of Placement Agent</font></i>,&#148; and &#147;<i><font style="font-style:italic;">Certain
Relationships among the Selling Stockholders and Intrusion&#151;Stonegate Securities</font></i>.&#148;</p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other
than Mr.&nbsp;Gero, Mr.&nbsp;Paxton and the affiliates of Stonegate, Mr.&nbsp;Griffith
and Mr.&nbsp;Shelmire, none of the selling stockholders has had a material
relationship with us within the past three years other than as a result of the
ownership of shares or our common stock or other securities. See &#147;<i><font style="font-style:italic;">Certain Relationships among the Selling Stockholders
and Intrusion</font></i>.&#148;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="294" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="64" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:47.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Shares<br>
  Beneficially<br>
  Owned<br>
  Before</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Shares</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="143" colspan="7" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:107.2pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Shares&nbsp;Owned<br>
  After&nbsp;the&nbsp;Offering</font></b></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="133" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:99.6pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Name&nbsp;of&nbsp;Selling&nbsp;Stockholder</font></b></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt 0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="155" valign="bottom" style="padding:0pt .7pt 0pt 0pt 0pt .7pt 0pt 0pt;width:115.9pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt 0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="64" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:47.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Offering(1)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt 0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="45" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Offered</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt 0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="84" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:63.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Number</font></b></p>
  </td>
  <td width="12" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="47" colspan="3" valign="bottom" style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:35.4pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Percent</font></b></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt 0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Alpha&nbsp;Capital&nbsp;AG(2)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">172,019</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">172,019</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bluegrass&nbsp;Growth&nbsp;Fund,&nbsp;L.P.(3)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">98,808</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68,808</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30,000</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Enable&nbsp;Growth&nbsp;Partners&nbsp;LP(4)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">585,245</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">172,019</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">413,226</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Enable
  Opportunity Partners LP(5)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34,403</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34,403</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gero, James F.(6)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">453,882</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41,285</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">412,597</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Griffith, Scott
  R.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,766</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,766</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nite Capital
  L.P.(7)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">274,019</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">172,019</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">102,000</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Paxton, G.
  Ward(8)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">993,564</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">82,569</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">910,995</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.7</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payne, Marshall
  R.(9)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">137,731</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34,791</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">102,940</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shelmire, IV,
  Jesse B.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,765</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,765</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCMP3 Partners
  L.P.(10)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99,600</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69,000</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30,600</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:220.5pt;">
  <p style="margin:0pt 0pt .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total(11)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,876,802</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.1pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">874,444</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="55" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,002,358</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="12" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:8.8pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:6.2pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22.5</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.2pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="133" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="155" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="4" style="border:none;"></td>
  <td width="55" style="border:none;"></td>
  <td width="4" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="45" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="14" style="border:none;"></td>
  <td width="55" style="border:none;"></td>
  <td width="14" style="border:none;"></td>
  <td width="12" style="border:none;"></td>
  <td width="8" style="border:none;"></td>
  <td width="25" style="border:none;"></td>
  <td width="14" style="border:none;"></td>
  <td width="14" style="border:none;"></td>
 </tr>
</table>

</div>

<div style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="left" style="width:120.0pt;">

</font></div>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Less
than 1%</p>

<p style="font-style:italic;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Footnotes to
Selling Stockholder Table:</font></i></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Beneficial ownership is
calculated in accordance with the rules&nbsp;of the Securities and Exchange
Commission in accordance with Rule&nbsp;13d-3(d)(1). In computing the
number of shares beneficially owned by a person and the percentage ownership of
that person, shares of common stock subject to options or warrants held by that
person that are currently exercisable or will become exercisable within 60 days
following January&nbsp;13, 2006 are deemed outstanding. However, these shares
are not </p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">18</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='18',FILE='C:\fc\17223743186_D11389_753616\2791-1-di.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt 20.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">deemed outstanding for the
purpose of computing the percentage ownership of any other person. Unless
otherwise indicated in the footnotes to this table, the persons and entities
named in the table have sole voting and sole investment power with respect to
all shares beneficially owned, subject to community property laws where
applicable.</font></p>

<p style="margin:0pt 0pt 6.0pt 20.0pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain shares of
common stock shown as beneficially owned are issuable upon conversion of the 5%
preferred stock or exercise of warrants we issued in a private placement on March&nbsp;25,
2004. Under the terms of these shares preferred stock and warrants, the shares
of 5% preferred stock are convertible and the warrants are exercisable only to
the extent that the number of shares of common stock issuable pursuant to those
securities, together with the number of shares of common stock owned by the
relevant person and its affiliates (but not including shares of common stock
underlying unconverted portions of the 5% preferred stock or unexercised
portions of the warrants) would not exceed 9.9% of the then outstanding shares
of common stock as determined in accordance with Section&nbsp;13(d)&nbsp;of the
Exchange Act. In addition, certain shares of common stock shown as beneficially
owned are issuable upon the conversion of Series&nbsp;2 5% preferred stock and
warrants issued in private placement on March&nbsp;28, 2005. Under the terms of
the Series&nbsp;2 5% preferred stock, the shares are convertible only to the
extent that the number of shares of common stock issuable upon conversion
thereof and upon the exercise of the warrants, together with the number of
shares of common stock owned by the relevant person and its affiliates (but not
including shares of common stock underlying unconverted portions of the Series&nbsp;2
5% preferred stock or unexercised portions of the warrants) would not exceed
4.99% of the then outstanding common stock as determined in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act. However, this restriction does not apply to Mr.&nbsp;Paxton
or Mr.&nbsp;Gero. Accordingly, the number of shares of common stock set forth
in the column under &#147;Shares Beneficially Owned Before Offering&#148; in the table
above exceeds the number of shares of common stock that they could beneficially
own at any given time through the ownership of these securities.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Konrad Ackerman and
Ranier Posch have voting and/or investment control over the shares held by
Alpha Capital AG. Mr.&nbsp;Ackerman and Mr.&nbsp;Posch disclaim beneficial
ownership of these shares.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes 20,000 shares
of our common stock issuable upon conversion of our Series&nbsp;2 5% preferred
stock and 10,000 shares of our common stock issuable upon the exercise of
existing warrants. Brian Shatz has voting and/or investment control over the
shares held by Bluegrass Growth Fund LP. Mr.&nbsp;Shatz disclaims beneficial
ownership of these shares.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes the equivalent
of 200,000 shares that may be issued upon conversion of Series&nbsp;2 5%
preferred stock, 63,130 shares that may be issued upon the conversion of 5%
preferred stock and 150,096 shares that Enable Growth Partners L.P. may acquire
upon the exercise of existing warrants. Mitch Levine has voting and/or
investment control over the shares held by Enable Growth Partners LP. Mr.&nbsp;Levine
disclaims beneficial ownership of these shares.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Mitch Levine has voting
and/or investment control over the shares held by Enable Opportunity Partners
LP. Mr.&nbsp;Levine disclaims beneficial ownership of these shares.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes the equivalent
of 60,000 shares that may be issued upon conversion of Series&nbsp;2 5%
preferred stock, 95,419 shares that may be issued upon conversion of 5%
preferred stock and 63,397 shares that Mr.&nbsp;Gero may acquire upon the
exercise of existing warrants. Also includes 4,168 shares that Mr.&nbsp;Gero
may acquire upon exercise of options that are currently exercisable or will
become exercisable within 60 days of January&nbsp;13, 2006.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes the equivalent
of 102,000 shares that may be issued upon the exercise of existing warrants. Keith
Goodman has voting and/or investment control over the shares held by Nite
Capital L.P. Mr.&nbsp;Goodman disclaims beneficial ownership of these shares.</p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">19</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='19',FILE='C:\fc\17223743186_D11389_753616\2791-1-di.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(8)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes the equivalent
of 4,996 shares held by Mr.&nbsp;Paxton in the Intrusion Stock Fund in the
Intrusion 401(k)&nbsp;Savings Plan. Includes the equivalent of 160,000 shares
that may be issued upon conversion of Series&nbsp;2 5% preferred stock, 222,646
shares that may be issued upon conversion of 5% preferred stock and 157,926
shares that Mr.&nbsp;Paxton may acquire upon the exercise of existing warrants.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes the equivalent
of 40,000 shares that may be issued upon conversion of Series&nbsp;2 5%
preferred stock, 31,807 shares that may be issued upon conversion of 5%
preferred stock and 31,133 shares that Mr.&nbsp;Payne may acquire upon the
exercise of existing warrants.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160; </font>Includes the equivalent of
30,600 shares that may be issued upon the exercise of existing warrants. Walter
Schenker and Steven Slawson have voting and/or investment control over the
shares held by TCMP3 Partners L.P. Mr.&nbsp;Schenker and Mr.&nbsp;Slawson
disclaim beneficial ownership of these shares.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160; </font>See
notes (3), (4), and (6)&nbsp;through (10)&nbsp;above.</p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><a name="CertainRelationshipsAmongTheSelli_211118"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain
Relationships among the Selling Stockholders and Intrusion</font></b></p>

<p style="font-style:italic;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Directors and
Executive Officers</font></i></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following
selling stockholders are directors and, in one instance, an executive officer
of our company:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>G.
Ward Paxton&#151;President, Chief Executive Officer, Chairman of the Board and
director; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>James F. Gero&#151;director.</p>

<p style="font-style:italic;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stonegate
Securities,&nbsp;Inc.</font></i></p>

<p style="margin:0pt 0pt 18.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stonegate Securities,&nbsp;Inc.
acted as our financial advisor and placement agent in connection with the
issuance of our Series&nbsp;3 5% convertible preferred stock and warrants to
the investors in the private placement. As compensation for acting as our
placement agent, we paid Stonegate an aggregate of $60,016.80. In addition, we
issued to Jesse B. Shelmire, IV and Scott R. Griffith, two affiliates of
Stonegate, warrants to purchase an aggregate of 27,531 shares of our common
stock at an exercise price of $2.58 per share.</font></p>

<div style="line-height:9.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">20</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='20',FILE='C:\fc\17223743186_D11389_753616\2791-1-di.htm',USER='jmsproofassembler',CD='Jan 17 22:38 2006' -->



<br clear="all" style="page-break-before:always;">

<div style="font-family:Times New Roman;">

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="LegalMatters_204759"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">LEGAL MATTERS</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The validity of the common
stock offered hereby will be passed upon for us by Patton Boggs LLP, Dallas,
Texas.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="Experts_204759"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">EXPERTS</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our consolidated financial
statements for the year ended December&nbsp;31, 2004 and 2003, appearing in our
Annual Report (Form&nbsp;10-KSB) for the year ended December&nbsp;31,
2004, have been audited by KBA Group LLP, independent registered public
accounting firm, as set forth in their report thereon included therein and
incorporated herein by reference. Such consolidated financial statements are
incorporated herein by reference in reliance upon such report given on the
authority of such firm as experts in accounting and auditing.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><a name="WhereYouCanFindAdditionalInformat_204759"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We file annual, quarterly and special reports, proxy
statements and other information with the Securities and Exchange Commission. You
may read and copy any document we file at the SEC&#146;s public reference room in
Washington, D.C. Please call the SEC at 1-800-SEC-0330 for
further information on the public reference rooms. Our SEC filings are also
available to you without charge at the SEC&#146;s web site at http://www.sec.gov.</font></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The SEC allows us
to &#147;incorporate by reference&#148; the information we file with them, which means
that we can disclose important information to you by referring you to those
documents. The information incorporated by reference is considered to be part
of this prospectus, and later information filed with the SEC will update and
supersede this information. We incorporate by reference the documents listed
below and any future filings made with the SEC under Section&nbsp;13a, 13(c),
or 15(d)&nbsp;of the Securities Exchange Act of 1934 until our offering is
completed.</font></p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
Annual Report on Form&nbsp;10-KSB for the year ended December&nbsp;31,
2004;</p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
Quarterly Reports on Form&nbsp;10-QSB for the quarters ended March&nbsp;31,
2005, June&nbsp;30, 2005, and September&nbsp;30, 2005;</p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>our
Current Reports on Form&nbsp;8-K dated March&nbsp;29, 2005, May&nbsp;3,
2005 (item 8.01), June&nbsp;15, 2005 and December&nbsp;6, 2005; and</p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>the
description of our common stock contained in our registration statement on Form&nbsp;8-A
filed with the SEC, including any amendments or reports filed for the purpose
of updating such description.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You may request a copy of these filings, at no cost,
by writing or telephoning us at the following address:</font></p>

<p style="margin:0pt 0pt 6.0pt 20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael Paxton<br>
Vice President and Chief Financial Officer<br>
Intrusion Inc.<br>
1101 E. Arapaho Road<br>
Richardson, Texas&#160; 75081<br>
(972) 234-6400</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You should rely only on the information incorporated
by reference or provided in this prospectus or the prospectus supplement. We have
authorized no one to provide you with different information. We are not making
an offer of these securities in any state where the offer is not permitted. You
should not assume that the information in this prospectus or the prospectus
supplement is accurate as of any date other than the date on the front of the
document.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">21</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='21',FILE='C:\fc\17223830735_D11389_753616\2791-1-dk.htm',USER='jmsproofassembler',CD='Jan 17 22:39 2006' -->



<br clear="all" style="page-break-before:always;">

<div>
 <div style="border:none;border-top:double windowtext 6.0pt;padding:0pt 0pt 0pt 0pt;"> <p style="border:none;margin:0pt 0pt .0001pt;padding:0pt;"><a name="scotch"></a><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p> </div>

<p style="margin:0pt 0pt 132.0pt;text-indent:20.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">We have
not authorized any person to make a statement that differs from what is in this
prospectus. If any person does make a statement that differs from what is in
this prospectus, you should not rely on it. This prospectus is not an offer to
sell, nor is it seeking an offer to buy, these securities in any state in which
the offer or sale is not permitted. The information in this prospectus is
complete and accurate as of its date, but the information may change after that
date.</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 48.0pt;page-break-after:avoid;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:16.0pt;">Intrusion Inc.</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 36.0pt;page-break-after:avoid;text-align:center;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;">874,444 Shares<br>
of Common Stock</font></b></p>

<div style="line-height:9.0pt;margin:0pt 0pt 16.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>

<p style="font-weight:bold;margin:0pt 0pt 18.0pt;page-break-after:avoid;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;">PROSPECTUS</font></b></p>

<div style="line-height:9.0pt;margin:0pt 0pt 132.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="160" noshade color="black" align="center" style="width:120.0pt;">

</font></div>

<p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">January 18, 2006</font></p>


 <div style="border:none;border-bottom:double windowtext 6.0pt;padding:0pt 0pt 0pt 0pt;"> <p style="border:none;margin:0pt 0pt .0001pt;padding:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p> </div>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\1720153720_D11389_753406\2791-1-ho.htm',USER='jmsproofassembler',CD='Jan 17 20:16 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
